Dukon Medical to Present Next-Generation Non-Invasive Brain Stimulation Suite at the 94th CMEF in Beijing

Shijiazhuang Dukon Medical Instruments Co., Ltd. invites global healthcare professionals, clinical leaders, and distributors to visit Booth B4T23 at the Capital International Convention and Exhibition Center from October 21 to 24, 2026.

BEIJING — October 9, 2026 — As the global healthcare sector converges on Beijing for the 94th China International Medical Equipment Fair (CMEF Autumn 2026), Shijiazhuang Dukon Medical Instruments Co., Ltd. has announced its official exhibition lineup. Dukon Medical will present its flagship portfolio of non-invasive neuromodulation systems and multi-scenario physical rehabilitation platforms at Booth B4T23.

Sprawling over 170,000 square meters, the 94th CMEF is set to bring together more than 3,000 international exhibitors and an estimated 120,000 professional attendees. Anchored in Beijing's strategy to foster a trillion-RMB health industry ecosystem, the autumn summit highlights technological integration across medical devices, digital healthcare, emergency medicine, and neurorehabilitation.

Driving Innovation in Non-Invasive Neuromodulation
At this year's expo, Dukon Medical will highlight its deep R&D roots in brain science and physical medicine, demonstrating devices engineered to penetrate the skull barrier non-invasively to promote central and peripheral neural pathway recovery.

Key featured systems at Booth B4T23 include:

1. Dual High/Low-Intensity Repetitive Transcranial Magnetic Stimulation (rTMS) System
Recognized as a cornerstone technology in modern neuro-psychiatry, Dukon’s integrated touchscreen rTMS system offers precise cortical stimulation for depression, stroke recovery, and cognitive disorders:

Dual-Intensity Switching: Seamlessly toggles between high-intensity magnetic output for deep neural activation and low-intensity modes for gentler therapy.

Continuous Duty Cycle: Equipped with a specialized liquid cooling system to prevent thermal attenuation during prolonged clinical sessions.

Bedside Flexibility: Compact, mobile chassis designed for both dedicated therapy suites and bedside ICU/inpatient deployment.

2. Transcranial Direct Current Stimulation (tDCS) Device
Utilizing micro-current electrical stimulation applied via scalp electrodes, this unit modulates cortical excitability to assist in cognitive re-education, pain management, and psychiatric recovery.

3. Transcranial Ultrasonic Electrotherapy System
A multi-modal system designed for cerebrovascular rehabilitation. By combining transcranial ultrasonic waves with bio-electrical stimulation of the cerebellar fastigial nucleus and peripheral nerves, the device targets early-stage thrombolysis, penumbra perfusion enhancement, and paralyzed limb re-education.

4. Transcranial Magnetic & Brain Reflex Therapy Systems
Integrating rTMS magnetic fields with cerebellar fastigial nucleus electrical stimulation, these dual-action platforms improve microcirculation, increase cerebral blood flow, and protect ischemic neural tissue while promoting peripheral nerve conduction.

5. Electroencephalogram (EEG) / Brain Wave Therapy Device
Designed for targeted neuro-protection, this device delivers simulated bio-electrical currents to activate endogenous protective mechanisms in the brain while providing functional electrical stimulation to affected muscle groups.

Expanding Full-Scenario Rehabilitation Frameworks
Beyond individual equipment manufacturing, Dukon Medical will share insights into its 6-Unit Rehabilitation Ecosystem, which bridges hospital care, primary health centers, and long-term home recovery across six specialized domains:

Neurological Rehabilitation

Mental Health Rehabilitation

Pediatric Rehabilitation

Traditional Chinese Medicine (TCM) Physical Therapy

Critical Care (ICU) Functional Recovery

Home-Care Rehabilitation

Dukon Medical invites international medical equipment distributors, hospital directors, and clinical researchers to visit Booth B4T23 to experience live product demonstrations and discuss global distribution opportunities.